PAI acquires Vamed: the advisors

Bär & Karrer and Willkie Farr & Gallagher advised PAI Partners (PAI) on the acquisition of Vamed Group’s rehabilitation business (VAMED) from Fresenius, advised by NKF and Latham & Watkins.

PAI will become the majority owner of the new company with 67 percent, while Fresenius will retain 33 percent. The rehabilitation business comprises 67 facilities with 9,100 beds and approximately 9,500 employees (FTE) in Germany, Austria, Switzerland, the Czech Republic and the United Kingdom.

The buyer’s advisors

Bär & Karrer acted with a team led by partner Philippe Seiler (pictured), which also comprised Romina Lauper, Luzius Bill and Yannick Wohlhauser (all corporate/M&A), Nicola Schön (employment), Djamila Batache and Judith von Gunten (both regulatory), Jonas Bornhauser (IP/IT data protection), Mani Reinert and Tim Meyer (both antitrust & competition) as well as Corrado Rampini and Patrick Neher (both real estate).

Corporate/M&A partner Axel Wahl led Willkie Farr & Gallagher’s team which acts as international counsel to PAI.

In-house legal team

Head of legal M&A/transformation Jan Winzen (pictured left) led Fresenius’ in-house legal team.

The seller’s advisors

Corporate/M&A partner Patrik Peyer (pictured right) led NKF’s team. He worked with associates Melchior Ebener and Manuel Hirlinger, junior associates Marco Sidler and Camille Stucker (all corporate/M&A), partner Janine Reudt-Demont (regulatory), senior associate Oliver Zbinden (real estate), senior associate Sven Kälin (tax) and associate Daniela Lötscher (tmployment).

Frankfurt/Düsseldorf M&A/private Equity partner Tobias Larisch led Latham & Watkins’ team, which acted as lead counsel for Fresenius.

PAI Partners

PAI Partners is a private equity firm that invests on a global basis. Since 1994, the firm has completed more than 100 investments in 12 countries, raising more than €24 billion from 60 exits, and has approximately €27 billion in assets under management.